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ABSTRACT
Objective: The study’s purpose has been to estimate the prevalence of HIV/TB coinfection in patients 
submitted to treatment of multidrug-resistant tuberculosis (MDR-TB) at a referral hospital in Rio de Janeiro 
city. Methods: It is a cross-sectional study that was carried out over the period from March to December 2016, 
whose population was composed of 40 patients undergoing treatment for MDR-TB. Statistical analysis was 
performed using the SPSS statistical program. Results: During the study time frame, 40 cases of MDR-TB were 
diagnosed, out of which 9 cases showed positive serology for HIV, representing a coinfection rate of 22.5%. In 
this group, the male gender predominated (85.29%) and with average age of 37.5 years old. The diagnosis of TB 
in coinfected patients occurred in the pulmonary clinical form (80%). In the smear test, (66.6%) presented a 
positive result, (74.9%) suggestive radiology and 100% of the patients presented resistance to rifampicin in the 
GeneXpert TB test. Conclusion: The drugs that presented the most resistance in this group were rifampicin, 
isoniazid and streptomycin (87.5%).
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RESUMO
Objetivo: Estimar a prevalência de coinfecção HIV/TB em pacientes 
submetidos a tratamento de TBMR em um hospital de referência do Rio 
de Janeiro. Método: Uma investigação transversal, cuja população foi 
composta por 40 pacientes em tratamento para TBMR, no período de 
março a dezembro de 2016. Para análise estatística utilizou-se o programa 
estatístico SPSS. Resultados: No período em estudo foram diagnosticados 
40 casos de TBMR, dos quais 9 mostraram sorologia positiva para HIV, o 
que representou uma taxa de coinfecção de 22,5%. Nesse grupo predominou 
o sexo masculino (85,29%) e a média 37,5 anos. O diagnóstico de TB nos 
coinfectados prevaleceu a forma clínica pulmonar (80%). No teste do 
esfregaço, (66,6%) apresentaram resultado positivo, (74,9%) radiologia 
sugestiva e 100% dos pacientes apresentaram resistência a rifampicina no teste 
do Gene Xpert. Conclusão: As drogas que apresentaram-se mais resistentes 
neste grupo foram  rifampicina, isoniazida e estreptomicina (87,5%). 
Descritores: Coinfecção, Tuberculose,  Epidemiologia.
RESUMEN
Objetivo: Estimar la prevalencia de coinfección VIH/TB en pacientes 
sometidos a tratamiento de TBMR en un hospital de referencia de Río 
de Janeiro. Método: Una investigación transversal, cuya población fue 
compuesta por 40 pacientes en tratamiento para TBMR, en el período de 
marzo a diciembre de 2016. Para análisis estadístico se utilizó el programa 
estadístico SPSS. Resultados: En el período en estudio se diagnosticaron 
40 casos de TBMR, de los cuales 9 mostraron serología positiva para el 
VIH, lo que representó una tasa de coinfección del 22,5%. En ese grupo 
predominó el sexo masculino (85,29%) y la media 37,5 años. El diagnóstico 
de TB en los coinfectados prevaleció la forma clínica pulmonar (80%). En 
la prueba del frotis, (66,6%) presentaron un resultado positivo, (74,9%) 
radiología sugestiva y el 100% de los pacientes presentaron resistencia a 
rifampicina en la prueba del Gene Xpert. Conclusión: Las drogas que se 
presentaron más resistentes en este grupo fueron rifampicina, isoniazida 
y estreptomicina (87,5%).
Descriptores: Coinfection, Tuberculosis, Epidemiología.
INTRODUCTION
Tuberculosis (TB) and human immunodeficiency virus/
acquired immunodeficiency syndrome (HIV/AIDS) are 
one of the leading causes of mortality from infectious 
diseases in resource-limited countries. In the individual 
the two pathogens, potentiate each other, accelerating the 
deterioration of immune functions. In the current context, 
HIV coinfection is the most important risk factor for the 
development of active TB, which increases the susceptibility 
to primary infection or reinfection and also the risk of 
reactivation of TB in patients with latent TB.
Infection with M. tuberculosis also has a negative 
impact on the immune response to HIV, accelerating the 
progression of HIV infection to AIDS.1
The World Health Organization (WHO) estimates that 
36.9 million people worldwide live with HIV,2 25% of whom 
will be coinfected with tuberculosis. In this population, the 
risk of developing TB is increased in relation to those who 
do not have the virus, due to the reduction of the defenses, 
which is a condition that has a great impact on the mortality 
rate in developing countries.3
Therefore, regarding the HIV/TB coinfection, only 
during 2014, from the 9.6 million people who developed 
TB worldwide, 1.5 million died from this disease and 0.4 
million were HIV positive.2,4 In Brazil, the numbers reached 
798,000 reported cases of people living with HIV/AIDS, 
and 63,189 new TB cases, then resulting in a coinfected 
rate of 9.7%.5
The Rio de Janeiro State concentrates 68 cases of TB 
per 100,000 inhabitants and the capital of Rio de Janeiro 
concentrates an incidence rate of 89.7 cases. An incidence 
considered high when compared to acceptable WHO data 
of 5/100,000.2
Adherence to antiretroviral and tuberculostatic therapies 
is an important measure in the reduction and control of 
HIV/TB cases, and thus the difficulty of adherence to 
treatment is an important factor for the continuation of 
the high rates of infection incidence and prevalence in 
the country, in addition to the increase in resistance to 
tuberculostatics, which is a problem due to the abandonment 
of TB treatment, strongly impacting the epidemiological 
situation of TB/HIV in Brazil.6,7
Thus, early diagnosis of coinfection and its correct 
treatment help reduce the incidence and mortality rate of the 
disease.8 Hence, knowledge of the prevalence of coinfection 
and its determinants among the HIV-infected population in 
a local context will help to reduce the burden of disease by 
facilitating the detection.9 The study’s goal was to evaluate 
the prevalence of multidrug-resistant tuberculosis (MDR-
TB)/HIV coinfection and the socio-demographic profile 
of MDR-TB/HIV coinfected cases in a referral hospital in 
Rio de Janeiro city.
METHODS
It is a cross-sectional study that is based on information 
collected from 40 patient records that are being treated 
for MDR-TB, at a referral hospital in Rio de Janeiro city, 
which is a public referral hospital in the care and treat-
ment of patients with MDR-TB. The data were collected 
over the period from May to September 2016 through 
medical records analysis. Inclusion criteria were, as follows: 
patients with a diagnosis of MDR-TB and HIV-positive 
serology, aged 18 years old or older, and treated with a 
basic regimen recommended by the National Program to 
Combat Tuberculosis. As exclusion criteria, they chose 
patient records that presented incomplete information and 
lack of understanding.
The data collected from the medical records were gen-
der, skin color, age, schooling, MDR-TB type and results 
of smear microscopy. Data were analyzed by the software 
SPPS (Statistical Package for Social Sciences) version 20.0.
Obeying the ethical and legal principles of research 
standards involving human beings, according to the Resolu-
tion No. 466/2012 and in Normative 001/2013, the project 
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was submitted to the approval of the Research Ethics Com-
mittee of the Escola de Enfermagem Anna Nery (EEAN) 
from the Universidade Federal do Rio de Janeiro (UFRJ), 
being approved under the protocol Certificado de Apresen-
tação para Apreciação Ética (CAAE) [Certificate of Presen-
tation for Ethical Appraisal] No. 54091116.7. 0000.5238. 
RESULTS AND DISCUSSION
In the study period from May to September 2016, 40 
cases of MDR-TB patients were diagnosed, of which 9 cases 
showed positive serology for HIV, representing a coinfec-
tion rate of 22.5%. The majority of the interviewees in this 
study were males (85.29%), average age was 37.5 years old, 
ranging from 18 to 62 years old. There was a rate of 55.5% 
for self-reported black skin color and 44.5% for white skin 
color. Considering the educational level analyzed among 
the participants, 44.4% had a college degree, 33.3% were 
incomplete high school and 22.3% were incomplete ele-
mentary school. The diagnosis of multidrug-resistant TB/
HIV coinfection was prevalent in clinical pulmonary form 
(80%). In sputum smear microscopy, 66.6% had positive 
bacilloscopy, 74.9% had suggestive radiology, 77.7% had a 
positive culture and 100% had resistance to rifampicin in 
the Xpert Gene test. The drug rifampicin, isoniazid, and 
streptomycin were the most resistant in this group (87.5%).
Tuberculosis is one of the leading causes of death from 
infectious diseases worldwide, especially after the HIV 
epidemic event.10
In this study, 40 cases of MDR-TB were diagnosed during 
the study period. With monoresistance pattern of (35%), and 
multiresistance pattern of 65%. In Brazil in 2015, there were 
1,027 cases of multidrug-resistant tuberculosis. Concerning 
the pattern of resistance of the cases in 2015, 476 (46.3%) 
were monoresistant, 442 (43.0%) of multiresistance, 72 
(7.0%) of polyresistance, 8 (0.8%) of resistance and another 
29 (2.8%) with resistance pattern not defined at the time of 
diagnosis. Still considering the year 2015, it was observed 
that the majority of the patients were male (67.4%) and the 
age group from 15 to 54 years old (80.6%).14 These data were 
confirmed in this study where the majority of the patients 
were male 85.29% and the average age was 37.5 years old. 
Male prevalence in HIV/TB coinfection was also verified 
in studies conducted in Brazil, South Africa, Portugal, and 
China.11,12,13 Thus, male vulnerability to HIV/TB coinfection 
can be underlined.
Tuberculosis is the 4th leading cause of death from infec-
tious diseases and the 1st cause of death among defined 
infectious diseases of AIDS patients. This serious public 
health problem has deep social roots and is closely linked 
to poverty and poor income distribution, as well as the 
stigma that afflicts both family members and individuals.14
Tuberculosis can occur at any stage of HIV infection. 
The diagnosis in coinfection is similar to diagnosis in the 
general population. The differential is in the clinical symp-
toms, because in people infected with HIV, the disease may 
occur more frequently outside the lung and in a widespread 
manner in the body.2 Nonetheless, in this study the rate 
of extrapulmonary tuberculosis was 20%, then being the 
pulmonary tuberculosis predominant.
The rate of coinfection presented in this study is similar 
in the literature15 and below the incidence rate where a 
co-infection rate of 31.2% was found.16
In Brazil, fifteen percent of new cases of tuberculosis are 
among HIV-infected individuals, reinforcing the recom-
mendation for the systematic screening of TB for hospita-
lized patients with the HIV-related disease.17 HIV-infected 
patients who have advanced immunosuppression present 
more frequently the disease in the form of hematogenous 
dissemination with multiorgan involvement. Often negative 
smears, necessitating blood culture and invasive procedures 
for diagnosis.7,18 When assessed in this study, diagnostic 
tests for MDR-TB, 44% of patients had negative smear 
microscopy, (77.7%) had a positive result for Mycobacterium 
culture and 100% showed resistance to rifampicin in the 
GeneXpert TB test.
The need for timely treatment and diagnosis of both 
infections for the patient with HIV/TB coinfection is deter-
minant in the prognosis and reduction of deaths in this 
clientele.6,19 In 2015, in Brazil, the percentage of testing for 
HIV was 83.1%, and 18% of those tested had coinfection. 
A positive association was found between the AIDS coef-
ficient and the TB incidence rate from 2001 to 2014. With 
each increase of 1 case of AIDS per 100,000 inhabitants, 
there was a 1.5% increase in the incidence of tuberculosis.14 
Herein, a prevalence of 22.5% of coinfected was observed, 
a number above what was found in the country and above 
the rate of 14% found in the Rio de Janeiro State during 
2015.14,20 But confirmed in studies in the Rio Grande do 
Sul where the co-infection rate was 29.2%.15
The rate of coinfection in Brazil shows a dynamic of 
internalization of the disease, showing how social factors, 
to mention poverty and the lack of investments in effective 
prevention and treatment programs, influence and make 
difficult the coping of both pathologies, TB, which is the 
leading cause of death among infectious diseases defined 
in patients with HIV/AIDS.21 The early initiation of antire-
troviral therapy (ART) during treatment of TB is associated 
with a reduction in all causes of mortality in this group, and 
the early onset of ART in HIV patients reduces the risk of 
developing TB by approximately 65%.1 Nevertheless, recent 
studies indicate that, globally, only one-third of HIV/TB 
coinfected patients receive ART in time appropriate. The 
barriers in different aspects of the treatment emphasize 
the need of commitment of the health services with this 
clientele, through the integration of care and services at 
all levels of care.5
Hence, MDR-TB has a negative impact on adherence to 
treatment, as it further aggravates the HIV/AIDS patient 
profile and the need to make changes in the ART regimen, 
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due to drug interactions and an increase in the number 
of drugs ingested and reactions.2 As a coping strategy it 
is pointed out the Directly Observed Treatment, which is 
already established in Brazil for patients with MDR-TB 
undergoing treatment in the Family Health Strategy.22
The current situation of this disease in Brazil and its 
outstanding position in the classification of disease incidence 
in the world panorama, in addition to the high registers 
of multiresistant cases that do not respond to the known 
treatments, tend to be aggravated by the withdrawal of the 
monitoring of the indicators. The non-monitoring of disea-
se-related indicators will create a risk for the population, a 
decrease in financial and human resources for TB control 
activities, therefore, causing a significant deterioration of 
TB epidemiological indicators. 
CONCLUSIONS
The HIV/TB coinfection is a major global health issue. 
With socioeconomic vulnerability a significant effect on 
treatment outcomes among patients coinfected with HIV/TB 
in Brazil. Strengthening social support, incorporating alcohol 
abuse screening and counseling into current TB surveillance 
programs, and focusing interventions on specific age groups 
are interventions that can improve treatment outcomes. TB 
is a disease that most emblematically characterizes the social 
determination of poverty in the health/disease process of a 
population. The orientation of social assistance services is 
extremely important, enabling the protection of patients 
with tuberculosis, to help them overcome barriers imposed 
by prejudice and stigma. It is important to promote the joint 
massive work of social assistance networks, health network, 
and also to provide guidelines for enhancing the work of the 
professionals of the social assistance network towards tuber-
culosis bearing people. It should be noted that it also reflects 
the need to work more effectively with partners in the fight 
against this disease, whose control actions go beyond the 
health sector. Given the aforementioned context, we are con-
cerned about the current economic situation and the recessive 
fiscal policy implemented in the country and that directly 
affect the social determinants related to tuberculosis, such as 
income, access to work and employment, education, housing 
etc.; furthermore, they may be a threat of withdrawing the 
advances made by Sistema Único de Saúde (SUS) [Unified 
Health System] and other public policies and social programs. 
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